Conferences

Harry Glorikian Moderating Breakout Discussion

Topic

Cancer, a Molecular Pathology

Harry Glorikian, Founder & Managing Partner of Scientia Advisors will be moderating a dialog around cancer: Has the time come where we can treat cancer for what it is - a molecular disease rather than an anatomic malady?.

Some possible topics for discussion:

• Enabling technologies
• Key hurdles for Regulators, Reimbursers and Pharm
• Impact of potential changes in cancer care

For more information, visit the Molecular Med Tri-Con 2012 Website